Q1 2024 EPS Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Cut by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) – Stock analysts at Zacks Research lowered their Q1 2024 earnings per share estimates for DENTSPLY SIRONA in a research note issued to investors on Thursday, March 21st. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of $0.41 per share for the quarter, down from their previous forecast of $0.45. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.05 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2024 earnings at $0.53 EPS, Q3 2024 earnings at $0.52 EPS, Q4 2024 earnings at $0.56 EPS, FY2024 earnings at $2.02 EPS, Q1 2025 earnings at $0.50 EPS, Q2 2025 earnings at $0.57 EPS, Q3 2025 earnings at $0.57 EPS, Q4 2025 earnings at $0.72 EPS, FY2025 earnings at $2.37 EPS and FY2026 earnings at $2.78 EPS.

Other research analysts have also recently issued research reports about the company. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price objective on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. SVB Leerink assumed coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. Finally, Barrington Research reiterated an “outperform” rating and set a $41.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, March 1st. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $39.50.

Check Out Our Latest Stock Analysis on XRAY

DENTSPLY SIRONA Stock Down 2.1 %

XRAY stock opened at $32.75 on Friday. DENTSPLY SIRONA has a 1-year low of $26.27 and a 1-year high of $43.24. The business has a fifty day moving average price of $33.96 and a 200-day moving average price of $33.30. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The stock has a market capitalization of $6.79 billion, a P/E ratio of -52.82, a P/E/G ratio of 1.35 and a beta of 0.99.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. During the same period in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Norges Bank bought a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $114,207,000. Nuance Investments LLC raised its position in DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after purchasing an additional 2,702,457 shares during the period. Wellington Management Group LLP raised its position in DENTSPLY SIRONA by 83.1% during the first quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock valued at $270,829,000 after purchasing an additional 2,497,773 shares during the period. Generation Investment Management LLP raised its position in DENTSPLY SIRONA by 43.4% during the fourth quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after purchasing an additional 1,998,012 shares during the period. Finally, Silvercrest Asset Management Group LLC raised its position in DENTSPLY SIRONA by 242.2% during the second quarter. Silvercrest Asset Management Group LLC now owns 2,100,859 shares of the medical instruments supplier’s stock valued at $84,076,000 after purchasing an additional 1,486,931 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 29th will be paid a $0.16 dividend. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.95%. DENTSPLY SIRONA’s dividend payout ratio is -90.32%.

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.